Public Health and Research Reforms in Controlled Substances Act of 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Oversight and Government Reform, Natural Resources, Agriculture, and Transportation and Infrastructure, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Email me when HR 10923 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HR 10923. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill would change the federal Controlled Substances Act so its drug schedules reflect current medical science. It creates a new system for classifying substances, moves some decision‑making powers to different officials, and supports scientific study of controlled drugs. The changes aim to improve patient access, public health, and research while keeping abuse controls.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HR 10923
3 free questions a day, no accountSponsors
- Rep. Cohen, Steve [D-TN-9] (D) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HR 10923 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HR 10923 freeOr ask your AI assistant about HR 10923 directly:
Add to Claude, ChatGPT or Cursor